Mark Arnold Hagler - 17 Nov 2026 Form 4 Insider Report for NovaBridge Biosciences (NBP)

SEC form
4
Accepted by SEC
19 Nov 2026, 16:30:29 UTC
Prior SEC filing
10 Jul 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Mark Arnold Hagler filed Form 4 for NovaBridge Biosciences (NBP) on 19 Nov 2026.

Key facts

  • This page summarizes Mark Arnold Hagler's Form 4 filing for NovaBridge Biosciences (NBP).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 19 Nov 2026, 16:30.

Change

  • Previous filing in this sequence was filed on 10 Jul 2026.
  • Current net transaction value: .

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002126029 Primary reporting owner

Hagler Mark Arnold

Relationship
Chief Commercial Officer

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NBP transaction

Ordinary Shares

Purchase

Transaction value
Shares
+46,000
Change %
+20%
Price
$0.3430*
Shares after
276,000
Date
17 Nov 2026
Ownership
Direct
Footnotes
F1, F2, F3
NBP transaction

Ordinary Shares

Purchase

Transaction value
Shares
+184,000
Change %
+67%
Price
$0.3810*
Shares after
460,000
Date
18 Nov 2026
Ownership
Direct
Footnotes
F1, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer.

Footnote F2

Reported securities are represented by 20,000 ADSs.

Footnote F3

The price reported in Column 4 represents the converted sales price of the ADSs of $0.79.

Footnote F4

Reported securities are represented by 80,000 ADSs.

Footnote F5

The price reported in Column 4 represents the converted weighted average price per ADS of $0.8758. These ADSs were purchased in multiple transactions at prices ranging from $0.84 to $0.90 per ADS, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .